Dabrafenib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of dabrafenib that may be used in the treatment of non-small cell lung cancer (NSCLC), oncocytic, follicular, papillary, and Hurthle cell thyroid carcinomas; cutaneous melanoma, and certain histiocytic neoplasms, such as Erdheim-Chester disease and Langerhans cell histiocytosis.

**Synonyms:** - Dabrafenib Mesylate Regimen - Dabrafenib monotherapy - Tafinlar Regimen